ONDS

AutoModerator

Post is by: Patriot_tech and the url/text [ ](https://goo.gl/GP6ppk)is: /r/Squeeze_em/comments/1x2hiwp/veeas_short_interest_fell_96_before_its_47_friday/ The most important number of the week showed up Friday afternoon. FINRA's Sep 30 short interest, published Oct 9, put VEEA at **50,744** shares short. On Sep 15 it was **1,216,996**. We spent the week quoting the old figure, roughly 77% to 80% of the float. By the time VEEA closed up 47% on Friday, most of the shorts we kept describing were already gone. The market barely helped. SPY rose about 1.2% for the week and IWM fell about 0.9%, so the moves below were about the stocks. **How fresh this is:** Closes and volume are Nasdaq's daily history (Oct 2 to Oct 9). Short interest is the Sep 30 settlement via Nasdaq. Borrow is Curved Trading's IBKR feed as of Saturday morning, which reflects Friday. Filings are from EDGAR, checked Saturday morning. --- **What ran** * **$VEEA** finished at **$5.70**, up 71% from $3.33 a week earlier. Monday did most of it (+71.8% on 66.9M shares). Then came three red days, then Friday's run to **$7.09** on about 83M shares after Thursday evening's news that Veea is back in compliance with Nasdaq's listing rules. That's more than 50 times the 1.58M float. Borrow ended at **844.7%** with 15K shares to lend. * **$APUS** went from $4.59 to $7.13 on Tuesday and hit **$9.84** Wednesday. It closed Friday at $5.02, about 49% under that high. Short interest was only 10,346 shares at Sep 15 (we don't have its Sep 30 figure yet). * **$BMGL** gained 14% to $3.75 in the same week it priced 6M units at **$1.33**. **What faded** * **$MEDS** fell 20% to $2.96. Thursday's 14M-share pop (+18%) was mostly gone by Friday's close. Friday it filed an amended S-1 to register up to **34,462,057** resale shares. The filing counts **4,515,862** shares outstanding. * **$IPDN** hit $6.78 on Tuesday's 70.6M-share day and closed Friday at $3.53, about 48% lower. * **$ONDS** slid 7% to $6.73. The Oct 9 $7.50 calls we tracked all week expired out of the money. * **$TNON** lost 7.8% and **$BTCT** 12.2%, quietly. **What short interest did, Sep 15 to Sep 30** VEEA fell 96%, BTCT 95%, BMGL 93%, TNON 89%, IPDN 46% and ONDS 4%. MEDS went the other way, up 22% to 525,081 shares. BIAF also rose, from 71,167 to 115,467. **What we got right** We said MEDS looked like shorts betting against the balance sheet, not a crowd waiting to get squeezed. The S-1/A is that balance sheet showing up. We flagged TNON, BTCT and BMGL because each had stock waiting behind the short interest, and BMGL priced at $1.33 while the stock traded above $3. We called ONDS a disagreement, not a trap. **What we got wrong** Two things. First, we leaned on a three-week-old short count. VEEA's borrow stayed brutal, which is why our standing rule kept it on the list, but "80% of float short" was mostly history by Sep 30. We had the right stock and the wrong fuel. Second, we dropped **$BIAF** after Tuesday. On Thursday it ran as much as 52% to **$9.38** on a Japan patent notice, traded 35.3M shares, and the company priced a roughly $4M offering at **$6.122** the same day. It closed Friday at **$4.725**. A spike followed by an offering is exactly the risk we write about, and we weren't watching it. A fee is not a squeeze. This week, an old short count wasn't one either. When the official count is two weeks old, what do you trust more: the borrow fee, or the number of shares available to lend? *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/CryptoMarkets) if you have any questions or concerns.*

AutoModerator

Post is by: Patriot_tech and the url/text [ ](https://goo.gl/GP6ppk)is: /r/Squeeze_em/comments/1x0q7kr/thursday_watchlist_oct_8_veea_tnon_meds_btct_bmgl/ Nothing on our squeeze screen scored 3 of 4 on Wednesday, so this is a board of near-misses, and we're calling them that. VEEA stays on under our standing update. TNON, BTCT and BMGL are new, and each one has registered stock or warrants sitting behind the short interest. MEDS stays from yesterday. APUS, IPDN and ONDS come off: all three still score 1 of 4. **How fresh this is:** Closes, ranges and volume are Wednesday's regular session, 3 PM CT close (Nasdaq, Yahoo). After-hours prices are the after-hours close, ~7:00 PM CT, from Nasdaq and StockAnalysis. After-hours volume is a rough figure: Nasdaq's full-day total minus Yahoo's regular-session count. Borrow and shares available are Curved Trading's IBKR feed as of 7:32 PM CT. Short interest is still the Sep 15 settlement. The Sep 30 numbers still weren't out on StockAnalysis or Nasdaq at 7:40 PM CT. Filings are from EDGAR, rechecked at about 7:55 AM CT Thursday, with nothing new overnight on any of the five. **Premarket lines** are Nasdaq's last premarket trade as of about 7:53 AM CT Thursday, and **borrow** was refreshed from Curved's 7:47 AM CT feed. Premarket volume is thin, so recheck everything at the open. **Squeeze screen:** We score four things: short interest of at least 20% of float, borrow of at least 50%, utilization of at least 90%, and a dated catalyst inside two weeks. We don't have a utilization figure we can verify, so the best possible score is 3. This time we went past Curved's top-50 borrow board and also checked borrow on all 100 names on StockAnalysis's most-shorted list, plus Curved's fee-spike and mover lists. Five names had both the crowd and the fee, on numbers we trust. None had a date on the calendar. Three more (MGN, AGRZ, WETO) looked 50%+ short on a screener and came apart in the filings: two reverse splits landed after the Sep 15 count, and one share count is out of date. --- **1) $VEEA: down again, on a quarter of Tuesday's volume** * Closed **$4.71**, down 4.7% from Tuesday's **$4.94**, in a range of $4.55 to $4.98. That's also 3% to 4% under Tuesday's after-hours close of $4.86 to $4.89. * About **473K** shares traded in the regular session, against roughly 1.8M Tuesday and 66.9M Monday. * After hours: **$4.63 to $4.66** at the after-hours close, ~7:00 PM CT, depending on the feed (Nasdaq vs. StockAnalysis), so down 1.1% to 1.7% from the regular close, on roughly **10K** shares. No filings or news after the bell. * Borrow is **783.2%** with **55K** available after the bell (last changed 5:17 PM CT). At the regular close it was 799.4% with 35K. Tuesday's regular close was 810.9% with 30K, and Wednesday morning showed 803.3% with 25K. Supply more than doubled in a day, which is worth watching. * Short interest **1.22M** at Sep 15, about 80% of the **1.52M** float (StockAnalysis). Days to cover 0.11. * No new filings since Tuesday's 4:25 PM CT 8-K, which put a director on the audit committee. NovaGen is still a non-binding term sheet, with no definitive agreement or vote date on EDGAR. Curved still flags the Aug 13 424B5 ($75M) as an ATM, with usage not broken out. * SSR was on Wednesday, carried over from Tuesday. Wednesday's low was 7.9% under Tuesday's close, short of Rule 201's 10% trigger, so the restriction should be off Thursday. Check your platform's flag. * Premarket: **$4.38**, down 7.0% from the regular close, on about **29K** shares by 7:53 AM CT. Borrow still **783.2%**, with availability up again to **60K** as of 7:47 AM CT. Curved still shows SSR on, so check your platform's flag before you trust our math on Rule 201. * Fade check: the fee is far above 50%, availability is far under 500K even after doubling, and there's no new offering. Not fading. * Screen: short interest 80.01% of float, borrow 783.2%, utilization not in our notes, no dated catalyst inside two weeks (earnings estimated Nov 13). 2 of 4. *What the numbers don't prove:* Two straight down days with the fee near 800%. The borrow says shorting is still hard. It doesn't say anyone is losing sleep over it. *What takes it off the board:* The fee drops under 50%, or more than 500K shares show up to lend, two sessions running. A new offering that supplies the shorts does it in one. **2) $TNON (Tenon Medical): the screener says 87% short, the S-3 says closer to 20%** * Closed **$3.50**, down 5.8% from **$3.715**, in a range of $3.38 to $3.64, on about **354K** shares (423K Tuesday). * After hours: **$3.44** at the after-hours close, ~7:00 PM CT, on both Nasdaq and StockAnalysis, down 1.7% from the regular close, on roughly **2K** shares. No filings or news after the bell. * Borrow is **335.5%** with **75K** available (last changed 4:47 PM CT). Tuesday's close was 330.7% with 100K. * Short interest **539,306** at Sep 15. StockAnalysis shows that as 86.87% of a 620,827-share float. The S-3 filed Oct 5 counts **2,688,735** shares outstanding as of Oct 1. Float can't be bigger than that, so the short interest is at least about 20% of float. That still clears our bar, barely. The 1-for-35 reverse split was Aug 10, before the count, so the split isn't the problem. The new shares are. * That S-3 registers the resale of **858,269** shares from Series B warrants struck at **$5.02**, issued in a Sep 11 warrant inducement. * After Tuesday's close the company announced the full commercial launch of its SImmetry+ SI joint screw. There's no date attached to anything after that. * Premarket: **$3.46**, down 1.1% from the regular close, on about **4K** shares by 7:46 AM CT. Borrow still **335.5%** with **100K** available as of 7:47 AM CT. * Screen: short interest at least 20% of float, borrow 335.5%, utilization not in our notes, no dated catalyst inside two weeks (earnings estimated Nov 12). 2 of 4. *What the numbers don't prove:* That 87% figure is the old share count talking. Run the same short interest against the new count and the percentage drops by about three-quarters. *What takes it off the board:* The Sep 30 short interest comes in under 20% of the new share count, or the stock climbs through $5.02 and those warrant shares show up. **3) $MEDS (DataMeds AI): fourth straight down close, and the borrow loosened** * Closed **$2.88**, down 6.2% from **$3.07**, in a range of $2.84 to $3.13, on about **351K** shares (about 640K Tuesday). It closed at $4.06 on Oct 1. * After hours: about **$2.87** at the after-hours close, ~7:00 PM CT (StockAnalysis), down 0.3% from the regular close. After-hours volume is not in our notes: Nasdaq's quote didn't update and StockAnalysis's day total runs below the regular session. No filings or news after the bell. * Borrow is **440.0%** with **20K** available (last changed 11:47 AM CT), down from 533.1% with 8K Wednesday morning. * It's on Nasdaq's Reg SHO threshold list in the Oct 6 file, the latest one posted. Curved counts 11 days. Curved showed SSR on Wednesday too. Wednesday's low was 7.5% under the prior close, so no fresh trigger. * Float **1.27M**, short interest **430,628** at Sep 15 (StockAnalysis). * No filings since Sep 17. The Aug 31 PRE 14C (written-consent actions) still has no definitive 14C behind it, so there's no effective date to put on the calendar. * Premarket: **$3.10**, up 7.6% from the regular close, on about **6.7M** shares by 7:53 AM CT, per Nasdaq. That's more than five times the float, and we found no filing or news behind it. Borrow still **440.0%**, with availability down to **15K** as of 7:47 AM CT. * Screen: short interest 33.85% of float, borrow 440.0%, utilization not in our notes, no dated catalyst inside two weeks (earnings estimated Nov 19). 2 of 4. *What the numbers don't prove:* The fee fell and supply more than doubled while the stock kept sliding. That looks like shorts getting comfortable, not cornered. *What takes it off the board:* Availability keeps climbing, or the fee slips under 50%. **4) $BTCT (BTC Digital): plenty of shorts, plenty of stock to borrow** * Closed **$1.08**, down 3.6% from **$1.12**, in a range of $1.05 to $1.10, on about **534K** shares (656K Tuesday). * After hours: about **$1.09** at the after-hours close, ~7:00 PM CT (StockAnalysis), up about 1% from the regular close, on roughly **13K** shares. No filings after the bell. * Borrow is **253.5%** with **1.2M** shares available (last changed 1:32 PM CT). Tuesday's close was 296.3% with 1.0M. * Short interest **4.15M** at Sep 15, 36.50% of an **11.37M** float (StockAnalysis). Days to cover 0.14. * A resale prospectus filed Sep 18 covers up to **18,421,050** shares, **12,280,700** of them from common warrants, against **11,800,567** shares outstanding before it. Fully exercised, the count goes to about **30.2M**. * No filings since Sep 18. * Premarket: **$1.07**, down 0.9% from the regular close, on about **92K** shares by 7:44 AM CT. Borrow still **253.5%**, but availability dropped to **750K** from 1.2M as of 7:47 AM CT. * Screen: short interest 36.50% of float, borrow 253.5%, utilization not in our notes, no dated catalyst inside two weeks (earnings estimated Nov 11). 2 of 4. *What the numbers don't prove:* A big fee means very little when 1.2 million shares were sitting there to borrow last night. That's about a tenth of the company. This morning's 750K is still plenty. *What takes it off the board:* Availability keeps growing, or the fee follows it down under 50%. **5) $BMGL (Basel Medical Group): an offering that's effective but hasn't priced** * Closed **$3.28**, down 1.5% from **$3.33**, in a range of $3.18 to $3.28, on about **12.5K** shares. It's thin. * After hours: one print at **$3.25** around 6:30 PM CT (StockAnalysis), down 0.9%, on too few shares to move the day's total. No filings or news after the bell. * Borrow is **98.5%** with **45K** available (last changed 8:32 AM CT). Tuesday's close was 96.3%. * Short interest **159,585** at